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Background: The aim of the study was to analyze surgical and endovascular results in the treatment of acute type
B aortic dissection (B AAD).
Methods: Retrospective and observational analysis with patient inclusion between January 2001-December 2008
and follow-up ranged from 2 to 96 months (median = 47.2) was performed. Out of 51 consecutive patients with B
AAD, 11 (21.6%) had to undergo open surgery (OS) and 13 (25.5%) endovascular treatment (TEVAR).
Results: There was a significantly difference in early mortality in the TEVAR group (0/13,0%) vs OS group (4/
11,36.4%, P < 0.05) and in the incidence of paraplegia/paraparesis (OS 2,28.6% vs TEVAR 1,7.7%, P < 0.05), renal
failure (OS 3, 42.8% vs TEVAR 1, 7.7%, P < 0.05), respiratory failure (OS 2,28.6% vs TEVAR 1,7.7%, P < 0.05) and
cerebrovascular accident (OS 1,14.3% vs TEVAR 0,0%, P < 0.05). The late mortality at a follow-up was 30.8% (4/13) in
the TEVAR group and 42.8% (3/7) in the OS group, respectively (P = not significant). The cumulative survival rate
after 1, 3 and 8 years was 93%, 84%, and 69% in the TEVAR group and 86%, 71% and 57% in the OS group,
respectively. Endoleaks were diagnosed in 2/13 endovascular patients (15.4%).
Conclusions: TEVAR group had a significantly reduction in early mortality and postoperative complications. No
significant differences were found in terms of cumulative survival at follow-up. On this basis TEVAR could be
considered an option in the treatment of these complex cases with all proper reservation especially related to the
small sample sizes examined.
Background
The treatment of Stanford type B acute aortic dissection
(B AAD) still remains a formidable challenge in compli-
cated cases and the options are medical therapy, con-
ventional surgery or endovascular repair. The method of
choice is conservative with aggressive medical therapy
[1,2] using b- blockers, calcium-channel blockers and
nitroglycerin to control heart rate and to maintain a sys-
tolic blood pressure less than 110 mmHg so lowering
aortic wall tension. A surgical approach is reserved in all
cases with complicated course such as persisted pain,
rupture or impending rupture, visceral and/or leg ische-
mia with a mortality rate up to 50% [3] and high para-
plegia rate [4], despite improved surgical techniques and
perioperative care [5]. The recent review presented by
the International Registry of Acute Aortic Dissection
(IRAD) shows a surgical mortality of 27.8% and 62.5%
in patients with malperfusion and rupture, respectively
[6]. On this basis the application of thoracic endovascu-
lar aortic repair (TEVAR) has been introduced as alter-
native surgical option but its role remains to be debated
with controversial opinions [7]. Many studies have
examined a heterogeneous population of patients
including acute and chronic type B aortic dissection
with immediate versus delayed treatment and both com-
plicated and uncomplicated cases. For this reason, the
purpose of this study was to compare our surgical and
endovascular results in the treatment of complicated B
AAD and the patients enrolled were included in a multi-
disciplinary program called Magna Græcia AORtic
Interventional Project® * (MAORI
2002). * Correspondence: mastroroberto@unicz.it
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Methods
A consecutive series of 51 patients with B AAD were
admitted to our large community University Hospital
from January 2001 to December 2008. B AAD was
defined as nontraumatic dissection involving the des-
cending aorta with initial intimal tear distal from the ori-
gin of the left subclavian artery. Diagnosis was performed
in all patients with both echocardiography and computed
tomography (CT). Indications for a non-medical treat-
ment was determined by rupture, high suspicion of
impeding aortic rupture and visceral and/or peripheral
ischemia based on clinical evaluation and CT imaging in
the acute phase (within 14 days after the onset of symp-
toms). The signs of impending rupture were determined
by persisting pain despite adequate and aggressive medi-
cal therapy, evidence of aortic expansion and presence of
new ulcerlike CT projection. Organ and/or limb malper-
fusion were defined on the basis of clinical symptoms,
physical examination and imaging detection. All patients
received medical therapy as standard protocol with b-
blockers, nitroglycerin and, in the last years, fenoldopam
mesylate, a dopamine D1 - like receptor agonist used to
control blood pressure and to obtain an optimal visceral
perfusion. In all cases continuous arterial pressure moni-
toring, central venous cannulation for administration of
all medications and urine output monitoring were per-
formed. Pain resolved with controlled blood pressure and
analgesia with absence of signs of malperfusion was
observed in 27 (52.9%) and these cases were considered
as treated only with medical therapy.
The surgical patients were divided in two groups,
open surgery (OS) group with 11 patients (21.6%) and
TEVAR group with 13 patients (25.5%), and all data
were retrospectively analyzed. From 2002, considering
surgical high mortality rate, our treatment was
addressed also to the endovascular approach especially
in high-risk cases and all patients excluded from this
therapy were operated on conventional surgery. The
specific technical and clinical criteria of exclusion from
TEVAR will explained in a followed section ("TEVAR
technique description”). The preoperative characteristics
including the life-threatening complications of the two
groups are listed in Table 1.
Data from early mortality and postoperative complica-
tions as paraplegia or paraparesis, renal and respiratory
failure, myocardial infarction, ventricular arrhythmias,
congestive heart failure were also collected.
Follow-up data were obtained by retrospective reviews
and clinic visits and CT scan performed at 3, 6 and 12
months after aortic repair and annually thereafter, and
late survival rates do not include early mortality.
Operative technique in the OS group
In all patients the graft replacement between the distal
aortic arch and the descending thoracic aorta was per-
formed through a left posterolateral thoracotomy as pre-
viously described [8] preparing proximal and distal
aortic cuffs using biological glues (gelatine - resorcine -
formaldehyde, the socalled “French glue”, and recently a
two - component adhesive composed of purified bovine
serum albumin and glutaraldehyde - BioGlue®, CryoLife
Inc, Kennesaw, GA, USA) and external strips of Teflon
(Impra Inc, subsidiary of L.R. Bard, Tempe, AZ, USA)
felt to reinforce the wall. 9 patients (77.8%) required the
replacement of proximal half of descending aorta and 2
patients (22.2%) needed repair also in the distal half.
Briefly our surgical approach involved cerebrospinal
fluid drainage and perfusion of the distal aorta. All
patients were positioned on the operating table in the
lateral position with the abdomen and the pelvis turned
so that the groin was at a 45° angle to the table to allow
cannulation of the femoral vessels for partial femoro-
femoral extracorporeal circulation. The proximal clamp
was placed just below the origin of left subclavian artery









Patient total 11 13
Age, years 70.2 ± 7.8 74.3 ± 8.4 < 0.05
Sex
Male 8 (72.7) 7 (53.8) NS
Female 3 (27.3) 6 (46.2) NS
Hypertension 9 (81.8) 10 (76.9) NS




1.2 ± 0.5 1.3 ± 0.4 NS
CAD 1 (9.1) 1(7.7) NS
COPD 7 (63.6) 8 (61.6) NS
Previous CVA 2 (18.2) 1 (7.7) NS
Prior AAA repair 1 (9.1) 1 (7.7) NS
Signs of aortic rupture 3 (27.3) 4 (30.8) NS
AAA = abdominal aortic aneurysm; CAD = coronary artery disease; CVA =
cerebrovascular accident; COPD = chronic obstructive pulmonary disease;
OS = open surgery; SD = standard deviation; TEVAR = thoracic endovascular
aortic repair; NS = not significant
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subclavian artery in 2 cases. The presence of a dissected
aorta was considered contraindication to intercostal
artery reimplantation. A cerebrospinal fluid catheter was
inserted before the operation at the level of L3 or L4,
and a pressure of 10 mm Hg or below was maintained.
This pressure was monitored for 48 hours after the
operation in the absence of lower extremity deficits. The
drainage catheter was reinserted if a neurologic deficit
developed after this period.
TEVAR technique
The option of TEVAR as first therapeutic approach in
cases with complicated type B AAD was considered
because of a) enhanced experience of our multidisciplin-
ary team, b) patients who were deemed a high-risk
open-repair candidate (age ≥ 75 years-old, severe
chronic obstructive pulmonary disease, serum creatinine
≥ 1.5 mg/dL, coronary artery disease with/without prior
coronary artery surgery, congestive heart failure), c)
favorable anatomic characteristics for TEVAR deter-
mined by the cardiovascular surgeon and interventional
cardiologist. Patients presenting a landing zone < 1.5 cm
with need to cover critical branch vessels, severe calcifi-
cation at the fixation site of the graft, significantly tortu-
ous and inadequate access vessels were excluded from
TEVAR. The procedures were done with local or gen-
eral anaesthesia using in all patients transesophageal
echocardiography (TEE) to visualize the correct place-
ment of the endoprosthesis, to achieve wire access in
the true lumen before stent graft deployment and to
confirm the exclusion of the false lumen. A cerebrosp-
inal fluid catheter was also inserted before the procedure
to detect neurologic events as spinal cord ischemia due
to sustained hypotension during stent-graft placement
or to coverage of major medullary arteries. The endo-
graft delivery was performed via femoral artery open
access and the other femoral artery or the right brachial
artery were used to obtain necessary angiograms. In all
patients we used the Talent™ endoluminal stent-graft
system (Medtronic Vascular Inc., Sunrise, FL, USA) and
balloon dilatation was not performed to prevent retro-
grade type A aortic dissection and/or aortic rupture [9].
In 3 patients (23%) the aortic coverage extended just
above the origin of the celiac artery without its coverage
using 2 stent-grafts, whereas in the other 10 patients
(77%) one device was used to achieve adequate distal
seal zone. Technical successo fT E V A Rw a sc o n s i d e r e d
the placement of patent endograft, exclusion of the false
lumen and absence of type I or III endoleaks.
Statistical analysis
Data were analyzed with the SPSS software version 15.0
for Windows (SPSS Inc, Chicago, IL, USA). Continuous
variables were presented as mean ± SD and categorical
variables as frequency and percentage. Categorial
variables were compared using the Fisher’se x a c tt e s t .
Student’s t-test was used to compare normally distribu-
ted continuous variables and Mann-Whitney U-test for
variables without normal distribution. A two-tailed P
value of less than 0.05 was considered to be statistically
significant. Survival was analyzed with the Kaplan-Meier
method [10] and was expressed as a percentage ±
Standard Deviation (SD).
Results
All patients medically treated were discharged from the
hospital without any complications.
As reported in Table 1 the TEVAR group was older
and had a higher but not significant frequency of signs
of aortic rupture. The incidence of chronic obstructive
pulmonary disease (COPD) was similar in the two
groups (P = not significant) and preoperative comorbid-
ities as hypertension and diabetes were slightly higher
but not significants in TEVAR and OS group, respec-
tively. The mean time from onset of symptoms to
operation was 4.2 ± 2.1 days in all patients, indepen-
dently from the type of procedure.
TEVAR group (Table 2)
Technical success of TEVAR was achieved in all patients
and the exclusion of false lumen and the absence of
endoleaks were confirmed by TEE. General anaesthesia
was reserved in only 2 cases (15.4%) because of haemo-
dynamic instability. The left subclavian artery was
crossed with the uncovered portion of the stentgraft in
eight cases and the covered segment in the other five
patients without subclavian- to - carotid bypass
intervention.
The early mortality defined as either in-hospital or
within 30 days was 0/13 (0%). The incidence of paraple-
gia/paraparesis, renal failure, respiratory failure with
prolonged intubation and cerebrovascular accident were
Table 2 Complications in survived patients of both the






No of patients 7/11 13/13
Paraplegia/paraparesis 2 (28.6) 1 (7.7) <0.05
Renal failure 3 (42.8) 1 (7.7) <0.05
Respiratory failure 2 (28.6) 1 (7.7) <0.05
Cardiac 1 (14.3) 1 (7.7) <0.05
Cerebrovascular accident 1 (14.3) 0 (0) <0.05
Bleeding 1 (14.3) 0(0) <0.05
Reinterventions 0 (0) 2(15.4) <0.05
OS = open surgery; TEVAR = thoracic endovascular aortic repair
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patient emerged from anaesthesia neurologically intact
but signs of significant lower extremity paresis were evi-
dent 20 days after the procedure probably due to
delayed occlusion of a major medullary artery. No
access-related complications in the TEVAR group were
documented.
The postoperative length of stay was significantly
shorter than the OS group at a median of 6 days versus
16 days. (P < 0.05).
The late mortality at a follow-up, ranged from 2 to 96
months (median = 47.2), was 30.8% (4/13). The cumula-
tive survival rate after 1, 3 and 8 years was 93%, 84%,
and 69% (Fig. 1). Two endoleaks (15.4%) were revealed
by CT scan at two and six months, respectively, one
proximal endoleak probably due to poor seal of the graft
was resolved by balloon dilatation and one distal endo-
leak was treated by an adjunctive stent-graft. On this
basis a p value < 0.05 was found comparing results
between OS and TEVAR groups in terms of late
reinterventions.
OS group (Table 2)
Early mortality was 36.4% (4 patients/11)
One intraoperative death (9.1%) occurred in a patient
who had a dramatic anterolateral aortic rupture, 1 perio-
perative death (9.1%) was related to an anteroseptal
myocardial infarction, 2 patients (18.2%) presented mul-
tiorgan failure and in 1 (9.1%) patient the postoperative
course was complicated by renal failure and extensive
bowel infarction.
Complications of the 7 surviving patients are summar-
ized in Table 2. Paraplegia/paraparesis was seen in 2
cases (28.6%): one case of paraparesis, defined as weak-
ness of both legs, was completely resolved six months
after the operation while one case of paraplegia, defined
as paralysis of both legs, was unresolved at follow-up.
Renal failure needing haemodialysis occurred in 2
patients and one patient presented left hemiplegia
because of cerebrovascular ischemic accident diagnosed
by CT scan. Moreover one patient was reoperated on
because of perianastomotic bleeding and required addi-
tional suture and external Teflon felt. The late mortality
Figure 1 Comparative survival analysis of OS (dashed line) and TEVAR (solid line) groups by Kaplan-Meier method.
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3 and 8 years was 86%, 71% and 57% (Fig. 1). No late
surgical complications as pseudoaneurysm, infection of
the grafts or fistulae from the graft to adjacent organ
were diagnosed in this group.
Discussion
Type B AAD is not considered as life-threatening as
acute type A aortic dissection and medical management
must be preferred with a low mortality rate [5,11].
These results are confirmed also in our series of medi-
cal-treated patients with no cases of hospital mortality.
Patients with life-threatening complications as rupture,
signs of impeding rupture as new ulcerlike projection,
expanding false lumen or persistent symptoms and visc-
eral and/or limb malperfusion are at high risk and
r e q u i r eam o r ea g g r e s s i v ea p p r oach representing a very
clinical challenge. In this setting TEVAR, open surgical
aortic graft replacement, flap fenestration by catheteriza-
tion or conventional surgery, extra-anatomic surgical
bypass have been proposed as treatment in an emer-
gency fashion. The primary objective of both OS and
TEVAR approaches are obviously strictly related to
reduce the risk of death and to minimize the complica-
tions by excluding proximal intimal tear, removing asso-
ciated aneurysmal disease and maintaining a complete
distal perfusion. The issuing advent of endovascular pro-
cedures has extended the number of patients potentially
suitable for aortic repair by a minimally invasive option
with a reduction in terms of mortality and morbidity
[12-14] but some limitations have been questioned by
the Expert Consensus Document recently published [7].
These limitations as the low probability to eliminate all
flow in the false lumen, the remaining risk for late
aneurysmal degeneration and aortic rupture are refer-
able to chronic type B aortic dissection and must be
considered quite reasonable. Based on the INSTEAD
(INvestigation of STEnt grafts in patients with type B
Aortic Dissection) results reported in the Expert Con-
sensus Document [7] it is evident that TEVAR approach
appears adequate in the early postoperative phase but
presents no benefits when the risk of late aortic rupture
and the life expectancy are examined [7]. The increasing
relevance of thoracic endovascular repair has been
demonstrated in a recent paper by Patel and coworkers
[14] especially in a group of TEVAR patients older and
sicker than patients scheduled for conventional surgery
so the Author concludes that “The differences between
the groups (endovascular andc o n v e n t i o n a ls u r g e r y )
therefore only serve to strengthen our conclusion that
TEVAR should be the therapeutic option of choice in
the elderly patient population” (see “Panel Discussion”
at the end of the paper). Similarly our TEVAR group is
significantly older than OS group so that endovascular
approach could be considered the treatment of choice
in a subset of patients considering age a risk factor in
terms of morbidity and mortality. Type B AAD is quite
another matter so the primary goal is to reduce early
mortality and on this way TEVAR treatment is a valu-
able application if used with propriety of indications [7].
Our results confirm this tendency with a significantly
difference between the TEVAR group vs the OS
group especially in terms of early mortality (0% vs
36.4%, P < 0.05) and postoperative hospital stay
(P < 0.05). In any case the analysis of causes of hospital
mortality revealed that in the OS group one patient died
from acute myocardial infarction and one from renal
failure and bowel infarction so we concluded that prob-
ably these deaths are strictly related to a preoperative
status of coronary artery disease and to a dramatic evo-
lutive dissecting process respectively and were indepen-
dently from the technique used (OS vs TEVAR). In the
analysis of postoperative complications as paraplegia,
renal and respiratory failure, cardiac arrhythmias and
cerebrovascular accident a difference in favour of the
TEVAR group was also found (Table 2). Moreover these
complications appear to be strictly related to the proce-
dure itself but not determined by possible preoperative
risk factors as age. Several studies have documented sig-
nificant morbidity correlated to TEVAR for type B AAD
as acute or delayed retrograde type A dissection [15],
paraplegia[16], stroke [16], access-related complications
[17], endoleaks [16], visceral ischemia [16]. In our series
of patients undergoing endovascular treatment no retro-
grade type A dissection, stroke, visceral ischemia and
access-related complications were diagnosed. The inci-
dence of paraplegia (1/13, 7.7%) was less in the TEVAR
than in the OS group with a percentage of endoleaks of
15.4% (2/13). As previously reported [18] we believe
that the high incidence of a catastrophic complication as
retrograde type A dissection [9] may be prevented by
the use of a stentgraft with an appropriate size not
requiring balloon dilatation and paying attention that
the guide wire is not misplaced in the false lumen.
The potential advantage of TEVAR therapy in all
patients in the acute phase of type B aortic dissection
with life-threatening complications probably fails in
stable dissection. Recently Nienaber and coworkers [19]
on behalf of the INSTEAD study group presented the
results in one hundred forty patients in stable condition
after at least two weeks the diagnosis of type B AAD, ran-
domly assigned to elective TEVAR in addition to medical
therapy or to optimal medical therapy alone. The 2 - year
cumulative survival rate was 95.6 +/- 2.5% in patients
with optimal medical therapy versus 88.9 +/- 3.7% in the
TEVAR group and no difference was found regarding the
aorta-related death rate. Moreover the comparison
between the aortic rupture rate and the progression was
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only in the aortic remodelling represented by the true-
lumen recovery and the false-lumen thrombosis (91.3%
of patients with TEVAR versus 19.4% of those who
received medical treatment alone -P < 0.001 -). These
results are in line with our suggestions confirming that
optimal medical therapy is the treatment of choice of
type B AAD with stable clinical conditions reserving a
more aggressive management as TEVAR in patients with
severe complications and to stabilize aortic wall so deter-
mining the false-lumen thrombosis.
We also analyzed the late mortality aorta-related with
3 late deaths in the OS group so demonstrating a clear
and a better survival rate in the TEVAR group. Never-
theless we do not consider this result a statement espe-
cially evaluating the limits represented by the low
number of patients enrolled.
There are still controversies regarding the optimal sur-
gical strategy in patients with type B AAD. Since 1993
we perform in all descending aorta operations femoro-
femoral bypass in normothermia to guarantee distal
organ perfusion and placing the proximal aortic clamp
between the left carotid artery and the left subclavian
artery or just below the left subclavian artery. Shimo-
kawa and colleagues [20] presented their results in the
treatment of acute type B dissection with distal arch
replacement and left heart bypass on mild hypothermia
showing reduction in the incidence of postoperative
fatal complications. The use of hypothermic circulatory
arrest avoiding aortic clamping between left carotid
artery and left subclavian artery improves surgical
results but a longer circulatory arrest determines a poor
outcome [6]. Lansman and coworkers [21] noticed that
in their series of 34 patients undergoing surgery for type
B AAD the use of hypothermic circulatory arrest was
reserved in 16 cases with no operative mortality and low
incidence of paraplegia. According to Shimokawa and
colleagues [20] and Lai and coworkers [22] we firmly
believe that proximal clamp can be safely placed in a
preferred fashion in all cases when dissection does not
involve the aortic arch. It is obvious that further investi-
gations will confirm this statement.
Moreover, our results demonstrate high incidence of
paraplegia/paraparesis in the OS group probably due to
the variable “acute dissection” itself as reported by Pan-
neton and Hollier [23] and Coselli and coworkers [24]
who conclude that only acute dissection increases the
risk of this neurologic complication and suggest critical
intercostal artery reattachment and atriodistal bypass as
safe procedures with predictable results.
Our data have suggested early encouraging results for
T E V A Rv sO Si np a t i e n t sw i t ht y p eBA A D ;h o w e v e r
the comparison at follow-up is not clearly defined with
a cumulative survival at 1 (93% vs 86%), 3 (84% vs 71%)
and 8 (69% vs 57%) years higher in terms of percentage
in the endovascular group.
Study limitations
There are some limitations of this study primarily
related to its retrospective and observational characteris-
tics including our evolving experience with TEVAR with
limitations and benefits, and considering that we have
used two different techniques during two different peri-
ods. In fact one of the indications to include patients in
the TEVAR group was the presence of important
comorbidities together with technical criteria already
explained. Moreover we are conscious that the size of
the cohort was small and not randomized, the two
groups of patients are not entirely comparable and the
time-related enrolment of patients was quite long.
Further randomized, controlled studies are needed to
address the best therapeutic strategy for complicated
type B AAD and factors associated with optimal short-
and long-term outcomes.
Conclusions
In summary, this study shows that TEVAR may be con-
sidered as therapeutic option in these series of compli-
cated patients with low early mortality and low
incidence of postoperative complications. Moreover
shorter postoperative length of stay may be considered
no negligible feature in the TEVAR group compared to
patients undergoing conventional surgery.
However, after all these reflections, the final act of this
study was not to assert the superiority of endovascular
p r o c e d u r eo v e rc o n v e n t i o n a ls u r g e r yn o rt oc o n s i d e ri t
as an alternative to surgical repair but to define further
knowledge on the role of endovascular stent-graft repair
in the treatment of all descending aorta diseases includ-
ing type B AAD. We believe that our work contains
meaningful information that can represent the basic
rationale for future larger studies in larger populations.
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